... formulation of 25-hydroxyvitamin D3 developed to treat secondary hyperparathyroidism (SHPT) which occurs due to Vitamin D insufficiency and stage 3 or 4 chronic kidney diseases (CKD). Vitamin D is not contained in any material quantity in the food ...
http://ift.tt/1cWIX5K
http://ift.tt/1cWIX5K
No comments:
Post a Comment